# Cue Biopharma, Inc.: Form 8-K, filed Jul 10, 2026

- Company: [Cue Biopharma, Inc.](/companies/cue.md) (CIK 1645460)
- Form: 8-K
- Filed: 2026-07-10
- Accepted by EDGAR: Jul 10, 2026, 17:29 ET
- Period: 2026-07-09
- Accession: 0001193125-26-301052
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645460/000119312526301052/d123955d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645460/000119312526301052/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645460/000119312526301052/d123955d8k.htm

Filed Jul 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-301052. Last ingested by Listed: Nov 11, 2026, 02:48 ET. No prices; not investment advice.
